Anna Rosenberg

Anna Rosenberg is a researcher at the University of Eastern Finland's School of Medicine, Institute of Clinical Medicine. She contributes to the Nordic-UK Brain Network (UEF-NBN) since January 1, 2022, focusing on multimodal interventions for dementia prevention.

Her research interests center on healthy aging, Alzheimer's disease prevention, and multidomain lifestyle interventions. She specializes in clinical trial methodology, neurodegenerative biomarkers, and public health strategies for cognitive decline risk reduction.

Publication trends indicate expertise in:

• Alzheimer's disease biomarker profiling
• Neurodegenerative disease intervention trials
• Data harmonization challenges in pooled analyses
• Behavioral change support systems for cardiovascular prevention
• Geriatric cognitive health research

She collaborates with international research groups including HATICE, CAIDE, and FINGER trials, emphasizing vascular risk factors and technology-assisted preventive strategies.